Accel Mark announced a business alliance with Medical Frontier Corporation, strengthening cosmetics sales and marketing support. Aiming to expand in the beauty medical field and enhance corporate value over the medium term.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3624","jir_company_name":"Accel Mark Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-23","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/3624-20260723-02.pdf","jir_short_summary":"Accel Mark announced a business alliance with Medical Frontier Corporation, strengthening cosmetics sales and marketing support. Aiming to expand in the beauty medical field and enhance corporate value over the medium term.","jir_summary":"### Overview of Business Performance\nThis document mainly explains the contents of Ace Mark's decision to establish a business alliance with Medical Frontier Corporation, including strategies for business expansion and future outlook. The alliance involves joint development of cosmetics and marketing support, aiming to expand the Beauty & Wellness and Medical Aesthetics businesses. In the medium term, the goal is to achieve a market capitalization of 20 billion yen, with objectives to improve consolidated performance and achieve early profitability.\n\n### Future Outlook\nAccel Mark expects this business alliance to lead to expanded sales channels, creation of cross-sell opportunities, improved customer acquisition efficiency, and promotion of new businesses. The Company aims to establish a business foundation in the medical aesthetics field at an early stage and strengthen competitiveness in growth markets. The impact on consolidated performance for the fiscal year ending September 2026 remains uncertain, but is expected to contribute to performance improvement over the medium to long term.","jir_financial_highlights":"Market Capitalization Target: 20 billion yen (Unknown)","jir_category":"","jir_hashtags":"#AccelMark, #IRRelated, #JapanStocks","jir_key_figures":"Market Capitalization Target: 20 billion yen\nPartnership Start Date: 2026-07-23\nPartner: Medical Frontier Corporation","jir_meta_title":"\u3010Accel Mark\u3011Medical Collaboration and Growth Strategy | July 2026","jir_meta_description":"Accel Mark has formed a partnership with a medical corporation to strengthen cosmetics sales and marketing support. The strategy aims for business expansion in the medical aesthetics field and to enhance corporate value over the medium term.","jir_og_title":"\u3010Accel Mark\u3011Medical Collaboration and Growth Strategy | July 2026","jir_og_description":"Accel Mark has partnered with a medical corporation to promote cosmetics sales and marketing support, aiming for business expansion in the medical aesthetics sector and increased corporate value.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61293,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-87004","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n